8
Oct
2024

Fujian South Pharmaceutical Co Ltd

Exhibitor at CPHI Milan 2024 stand 5F98, Contract Manufacturing and Services
About Us

Fujian South Pharmaceutical Co Ltd (FSP) was established in 2001, located in Mingxi County, Fujian Province, China. Today, FSP has become an important cGMP manufacturer for oncology APIs in China. FSP cultivates 7,000 acres of Taxus Wallichiana (Taxus yunnanensis), and it is the largest commercial utilizing in China. FSP is the main supplier for natural Paclitaxel, semi-synthesis Paclitaxel, Docetaxel, 10-DAB III (Taxus Baccata and Taxus Wallichiana) in the world. FSP is a main supplier for Gemcitabine, Irinotecan and the patented technologies for Docetaxel, Imatinib, and Erloitnib, etc.

...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 5F98, Contract Manufacturing and Services

Products Featured at CPHI Milan 2024

  • 5-aminolevulinic acid HCl

    Product 5-aminolevulinic acid HCl

    5-ALA HCl: 5-Aminolevulinic acid hydrochloride; 5-ALA methyl ester: 5-Aminolevulinic acid methyl ester hydrochloride.